glp 1 and pancreatitis PSCs GLP-1R: occurrence in normal pancreas, acute/chronic and effect of their activation by a GLP-1R agonist What adverse effects are associated

While the breadth of GLP-1 medicines clinical impact is striking, the review maintains a scientific and measured tone, highlighting the importance of further rigorous investigation to understand and optimize these therapies for diverse chronic conditions fully

10.1038/s41593-017-0009-9 228 YuT.LinW

Typical research doses fall in the 100-300 mcg range per administration, with 1-3 administrations per research day depending on protocol design and endpoint measurements

This potent oxidant induces ferroptosis by depleting glutathione (GSH), the cells principal soluble antioxidant, thereby compromising the primary defense against lipid peroxides

Extended follow-up studies would identify any delayed adverse effects and establish whether therapeutic benefits persist, diminish, or require continued treatment for maintenance